Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator.

Source:http://linkedlifedata.com/resource/pubmed/id/15642569

Am. J. Cardiol. 2005 Jan 15 95 2 274-6

Download in:

View as

General Info

PMID
15642569